041910 — Polaris AI Pharma Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapFalling Star

Annual income statement for Polaris AI Pharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	46,490	61,324	60,401	62,036	64,215
Cost of Revenue
Gross Profit	13,001	17,370	13,826	12,665	14,297
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	42,695	54,323	56,195	58,875	58,871
Operating Profit	3,795	7,000	4,205	3,162	5,344
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	19,056	19,391	7,773	-8,415	4,475
Provision for Income Taxes
Net Income After Taxes	15,228	15,733	6,875	-6,364	3,824
Net Income Before Extraordinary Items
Net Income	15,228	15,733	6,875	-6,364	3,824
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	15,228	15,733	6,875	-6,364	3,824
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,305	1,417	585	-545	327
Dividends per Share